Prof. Gal Markel is the Director of the Davidoff Cancer Center and Deputy Director of Rabin Medical Center, Beilinson, specializing for many years in the oncology of melanoma and in immuno-oncology. He holds both an MD and a PhD (in biology), and leads research teams that develop innovative treatments against melanoma in particular and cancer in general. In his work, Prof. Markel combines advanced medical technologies and clinical research, has accumulated extensive knowledge and clinical experience, has published more than 150 articles in leading journals, and is frequently invited to lecture at medical conferences around the world. Accordingly, Prof. Markel has gained international recognition in the field of melanoma. He serves in key national roles, is a member of many professional committees, and promotes innovative projects aimed at setting a high standard of care for cancer patients and positioning Israel as a leader in the field.
What is immunotherapy? Prof. Gal Markel
How does the immune system work against a cancerous tumor? Prof. Gal Markel
Prof. Gal Markel, Director of the Davidoff Cancer Center and Deputy Director of Rabin Medical Center, guiding medical students Tal Shabtai (Tel Aviv University) and Odaya Rotem (Ben-Gurion University)
Personal and human: matching the right treatment for oncology patients
Breakthrough medicine: Prof. Dan Schechtman hosts Prof. Gal Markel
Why does a cancerous tumor develop in the body? Dr. Gal Markel / TEDMED 2014
Interview with Prof. Gal Markel following a special ASCO conference for skin cancer patients. The Israeli Skin Cancer Association
🗞 November 2014 – Second-generation immuno-oncology drugs, PD-1 blockers.
🗞 August 2015 – Prof. Markel and his fight against the cancer’s cloak of invisibility.
🗞 June 2018 – Prof. Markel explains how immunotherapy works and how it is applied in patients with metastatic melanoma.
🗞 December 2019 – Prof. Gal Markel describes the next revolution in medicine at the Innovation in Health conference.
📖 May 2020 – Prof. Markel explains the immunological basis of new treatment approaches. “Bama” magazine of the Israel Cancer Association.
🗞 June 2020 – From Infomed, Prof. Markel – what are the targeted biological treatments for metastatic melanoma and how are they related to the presence of a mutation in the BRAF protein?
🗞 June 2026 The huge gap in skin cancer diagnosis in Israel revealed – YNET
🗞 June 2026 The skin cancer paradox: an Israeli study with a surprising discovery – Israel Hayom
